-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Nutra Pharma (OTCMKTS:NPHC) and Smart for Life (NASDAQ:SMFL) Head to Head Review
Nutra Pharma (OTCMKTS:NPHC) and Smart for Life (NASDAQ:SMFL) Head to Head Review
Nutra Pharma (OTCMKTS:NPHC – Get Rating) and Smart for Life (NASDAQ:SMFL – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, profitability, dividends and risk.
Earnings & Valuation
This table compares Nutra Pharma and Smart for Life's gross revenue, earnings per share and valuation.
Get Nutra Pharma alerts:Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Nutra Pharma | $100,000.00 | 21.12 | -$13.10 million | N/A | N/A |
Smart for Life | $9.02 million | 0.98 | -$7.77 million | N/A | N/A |
Smart for Life has higher revenue and earnings than Nutra Pharma.
Profitability
This table compares Nutra Pharma and Smart for Life's net margins, return on equity and return on assets.Net Margins | Return on Equity | Return on Assets | |
Nutra Pharma | 2,860.14% | -41.28% | 941.28% |
Smart for Life | -139.56% | -1,377.59% | -94.78% |
Analyst Ratings
This is a summary of current ratings for Nutra Pharma and Smart for Life, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Nutra Pharma | 0 | 0 | 0 | 0 | N/A |
Smart for Life | 0 | 0 | 1 | 0 | 3.00 |
Smart for Life has a consensus price target of $8.00, suggesting a potential upside of 3,159.98%. Given Smart for Life's higher possible upside, analysts plainly believe Smart for Life is more favorable than Nutra Pharma.
Insider & Institutional Ownership
0.0% of Nutra Pharma shares are owned by institutional investors. Comparatively, 0.4% of Smart for Life shares are owned by institutional investors. 61.5% of Nutra Pharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
About Nutra Pharma
(Get Rating)
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps, and neuropathic pain, as well as a topical gel for treating joint pain, and pain associated with arthritis and repetitive stress; Pet Pain-Away, a homeopathic, non-narcotic, non-addictive, and over-the-counter pain reliever to treat chronic pain in companion animals; Luxury Feet, an over-the-counter pain reliever and anti-inflammatory product to treat pain or discomfort due to high heels and stilettos; Nyloxin Military Strength for treating pain to the United States Military and Veteran's Administration; and Equine Pain-Away, an over-the-counter topical pain reliever to relieve pain in horses. It is also involved in developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases comprising human immunodeficiency virus/AIDS and herpes, as well as for general anti-viral applications; RPI-78 for pain and arthritis; and RPI-70 for pain. The company was incorporated in 2000 and is based in Plantation, Florida.
About Smart for Life
(Get Rating)
Smart for Life, Inc. acquires, develops, manufactures, operates, markets, and sells nutraceutical and related products in the United States and internationally. It offers natural health and wellness meal replacement products, including nutrition bars, cookies, soups and shakes, vitamins, and supplements; dietary supplements; nutritional supplements for athletes and active lifestyle consumers comprising powders, tablets, and soft gels; and various nutritional supplements. It sells its products through online market platforms. The company was formerly known as Bonne Santé Group, Inc. and changed its name to Smart for Life, Inc. in August 2021. Smart for Life, Inc. was founded in 2002 and is based in Miami, Florida.
Receive News & Ratings for Nutra Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutra Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
Nutra Pharma (OTCMKTS:NPHC – Get Rating) and Smart for Life (NASDAQ:SMFL – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, profitability, dividends and risk.
纽特拉医药(场外交易代码:NPHC-GET评级)和智能生活(纳斯达克:SMFL-GET评级)都是小盘医疗公司,但哪只股票更好?我们将根据两家公司的机构持股、收益、分析师建议、估值、盈利能力、股息和风险等方面的实力对它们进行比较。
Earnings & Valuation
收益与估值
This table compares Nutra Pharma and Smart for Life's gross revenue, earnings per share and valuation.
下表比较了纽特拉制药公司和Smart for Life公司的毛收入、每股收益和估值。
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Nutra Pharma | $100,000.00 | 21.12 | -$13.10 million | N/A | N/A |
Smart for Life | $9.02 million | 0.98 | -$7.77 million | N/A | N/A |
总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
纽特拉制药公司 | $100,000.00 | 21.12 | -1,310万元 | 不适用 | 不适用 |
生活中的智能 | 902万美元 | 0.98 | -777万美元 | 不适用 | 不适用 |
Smart for Life has higher revenue and earnings than Nutra Pharma.
Smart for Life的收入和收益高于纽特拉制药。
Profitability
盈利能力
Net Margins | Return on Equity | Return on Assets | |
Nutra Pharma | 2,860.14% | -41.28% | 941.28% |
Smart for Life | -139.56% | -1,377.59% | -94.78% |
净利润率 | 股本回报率 | 资产回报率 | |
纽特拉制药公司 | 2,860.14% | -41.28% | 941.28% |
生活中的智能 | -139.56% | -1,377.59% | -94.78% |
Analyst Ratings
分析师评级
This is a summary of current ratings for Nutra Pharma and Smart for Life, as reported by MarketBeat.com.
这是MarketBeat.com报道的纽特拉制药和Smart for Life的当前评级摘要。
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Nutra Pharma | 0 | 0 | 0 | 0 | N/A |
Smart for Life | 0 | 0 | 1 | 0 | 3.00 |
销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
纽特拉制药公司 | 0 | 0 | 0 | 0 | 不适用 |
生活中的智能 | 0 | 0 | 1 | 0 | 3.00 |
Smart for Life has a consensus price target of $8.00, suggesting a potential upside of 3,159.98%. Given Smart for Life's higher possible upside, analysts plainly believe Smart for Life is more favorable than Nutra Pharma.
Smart for Life的共识目标价为8.00美元,这意味着潜在的上涨幅度为3159.98%。考虑到Smart for Life的更高可能上行空间,分析师们显然认为Smart for Life比NuTRA Pharma更有利。
Insider & Institutional Ownership
内部人与机构所有权
0.0% of Nutra Pharma shares are owned by institutional investors. Comparatively, 0.4% of Smart for Life shares are owned by institutional investors. 61.5% of Nutra Pharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
纽特拉制药0.0%的股份由机构投资者持有。相比之下,Smart for Life 0.4%的股份由机构投资者持有。NUTRA Pharma 61.5%的股份由内部人士持有。强大的机构持股表明,对冲基金、捐赠基金和大型基金经理相信,从长期来看,一只股票的表现将好于大盘。
About Nutra Pharma
关于纽特拉制药公司
(Get Rating)
(获取评级)
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps, and neuropathic pain, as well as a topical gel for treating joint pain, and pain associated with arthritis and repetitive stress; Pet Pain-Away, a homeopathic, non-narcotic, non-addictive, and over-the-counter pain reliever to treat chronic pain in companion animals; Luxury Feet, an over-the-counter pain reliever and anti-inflammatory product to treat pain or discomfort due to high heels and stilettos; Nyloxin Military Strength for treating pain to the United States Military and Veteran's Administration; and Equine Pain-Away, an over-the-counter topical pain reliever to relieve pain in horses. It is also involved in developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases comprising human immunodeficiency virus/AIDS and herpes, as well as for general anti-viral applications; RPI-78 for pain and arthritis; and RPI-70 for pain. The company was incorporated in 2000 and is based in Plantation, Florida.
纽特拉制药公司是一家生物制药公司,主要在美国收购、许可和商业化制药产品和技术,以及用于治疗疼痛、神经疾病、癌症、自身免疫和传染病的顺势疗法和伦理药物。该公司提供尼洛辛和尼洛辛特效产品,用于治疗下腰痛、偏头痛、颈部疼痛、肩痛、抽筋和神经性疼痛的口腔喷雾,以及用于治疗关节疼痛、与关节炎和反复压力相关的疼痛的局部凝胶;宠物止痛药,一种顺势疗法,非麻醉性,非成瘾性和非处方药止痛剂,用于治疗同伴动物的慢性疼痛;豪华脚,非处方药止痛药和抗炎产品,用于治疗由于高跟鞋和高跟鞋引起的疼痛或不适;尼洛欣为美国军方和退伍军人管理局提供了治疗疼痛的军事力量;以及Equine Pain-Away,一种用于缓解马的疼痛的非处方局部止痛药。它还参与开发RPI-78M,用于治疗神经系统疾病和自身免疫性疾病,包括多发性硬化症、肾上腺脊髓神经病、肌萎缩侧索硬化症、类风湿性关节炎和重症肌无力;RPI-MN用于治疗包括人类免疫缺陷病毒/艾滋病和疱疹在内的病毒性疾病,以及用于一般抗病毒应用;RPI-78用于疼痛和关节炎;以及RPI-70用于疼痛。该公司成立于2000年,总部设在佛罗里达州的普兰特。
About Smart for Life
关于Smart for Life
(Get Rating)
(获取评级)
Smart for Life, Inc. acquires, develops, manufactures, operates, markets, and sells nutraceutical and related products in the United States and internationally. It offers natural health and wellness meal replacement products, including nutrition bars, cookies, soups and shakes, vitamins, and supplements; dietary supplements; nutritional supplements for athletes and active lifestyle consumers comprising powders, tablets, and soft gels; and various nutritional supplements. It sells its products through online market platforms. The company was formerly known as Bonne Santé Group, Inc. and changed its name to Smart for Life, Inc. in August 2021. Smart for Life, Inc. was founded in 2002 and is based in Miami, Florida.
Smart for Life,Inc.在美国和国际上收购、开发、制造、运营、营销和销售保健品及相关产品。它提供天然健康和健康膳食替代产品,包括营养棒、饼干、汤和奶昔、维生素和补充剂;膳食补充剂;运动员和积极生活方式消费者的营养补充剂,包括粉末、片剂和软凝胶;以及各种营养补充剂。它通过在线市场平台销售产品。该公司前身为邦桑特́集团,并于2021年8月更名为Smart for Life,Inc.。Smart for Life,Inc.成立于2002年,总部设在佛罗里达州迈阿密。
Receive News & Ratings for Nutra Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutra Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
接受《纽特拉医药日报》的新闻和评级-在下面输入您的电子邮件地址,即可通过MarketBeat.com的免费每日电子邮件时事通讯,收到有关纽特拉制药和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧